ProShare Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.4M Sell
45,661
-1,364
-3% -$157K 0.01% 552
2026
Q1
$5.62M Sell
47,025
-9,250
-16% -$1.21M 0.01% 526
2025
Q4
$7.66M Buy
56,275
+6,692
+13% +$963K 0.01% 395
2025
Q3
$7.31M Sell
49,583
-765
-2% -$106K 0.02% 402
2025
Q2
$6.51M Buy
50,348
+13,457
+36% +$1.63M 0.01% 448
2025
Q1
$4.41M Sell
36,891
-8,672
-19% -$1.07M 0.01% 546
2024
Q4
$5.29M Sell
45,563
-36,761
-45% -$4.65M 0.01% 503
2024
Q3
$11.1M Buy
82,324
+38,648
+88% +$5.17M 0.03% 318
2024
Q2
$5.92M Buy
43,676
+2,385
+6% +$324K 0.02% 464
2024
Q1
$5.34M Sell
41,291
-1,440
-3% -$174K 0.01% 485
2023
Q4
$4.89M Sell
42,731
-3,006
-7% -$300K 0.01% 499
2023
Q3
$4.16M Sell
45,737
-2,083
-4% -$215K 0.01% 516
2023
Q2
$5.39M Buy
47,820
+7,258
+18% +$768K 0.02% 491
2023
Q1
$4.25M Buy
40,562
+18,241
+82% +$1.91M 0.01% 511
2022
Q4
$2.47M Buy
22,321
+142
+0.6% +$14.9K 0.01% 589
2022
Q3
$1.94M Sell
22,179
-2,784
-11% -$253K 0.01% 625
2022
Q2
$1.95M Sell
24,963
-9,803
-28% -$809K 0.01% 649
2022
Q1
$2.96M Sell
34,766
-826
-2% -$79.1K 0.01% 648
2021
Q4
$4.27M Buy
35,592
+8,726
+32% +$1.08M 0.01% 603
2021
Q3
$3.32M Buy
26,866
+1,021
+4% +$131K 0.01% 602
2021
Q2
$3.1M Buy
25,845
+2,420
+10% +$276K 0.01% 621
2021
Q1
$2.46M Buy
23,425
+1,217
+5% +$123K 0.01% 633
2020
Q4
$2.26M Buy
22,208
+2,473
+13% +$232K 0.01% 605
2020
Q3
$1.66M Buy
19,735
+422
+2% +$32.8K 0.01% 608
2020
Q2
$1.25M Buy
19,313
+3,272
+20% +$216K 0.01% 650
2020
Q1
$1.04M Sell
16,041
-12,111
-43% -$954K 0.01% 591
2019
Q4
$2.22M Buy
28,152
+6,476
+30% +$504K 0.01% 600
2019
Q3
$1.73M Buy
21,676
+1,613
+8% +$127K 0.01% 619
2019
Q2
$1.68M Sell
20,063
-1,627
-8% -$130K 0.01% 627
2019
Q1
$1.71M Sell
21,690
-618
-3% -$45.1K 0.01% 633
2018
Q4
$1.49M Sell
22,308
-5,673
-20% -$392K 0.01% 630
2018
Q3
$2.23M Sell
27,981
-4,271
-13% -$319K 0.02% 579
2018
Q2
$2.17M Sell
32,252
-1,399
-4% -$102K 0.01% 607
2018
Q1
$2.59M Buy
33,651
+8,489
+34% +$628K 0.02% 565
2017
Q4
$1.72M Buy
25,162
+8,330
+49% +$553K 0.01% 652
2017
Q3
$1.05M Buy
16,832
+2,228
+15% +$133K 0.01% 720
2017
Q2
$809K Sell
14,604
-682
-4% -$35.5K 0.01% 795
2017
Q1
$768K Sell
15,286
-917
-6% -$44.7K 0.01% 850
2016
Q4
$802K Buy
16,203
+3,625
+29% +$184K 0.01% 873
2016
Q3
$660K Sell
12,578
-4,128
-25% -$202K 0.01% 834
2016
Q2
$746K Sell
16,706
-1,577
-9% -$68.5K 0.01% 808
2016
Q1
$748K Sell
18,283
-7,729
-30% -$285K 0.01% 829
2015
Q4
$949K Sell
26,012
-36,658
-58% -$1.33M 0.01% 757
2015
Q3
$2.06M Buy
62,670
+37,033
+144% +$1.25M 0.03% 471
2015
Q2
$950K Sell
25,637
-6,772
-21% -$246K 0.01% 797
2015
Q1
$1.14M Sell
32,409
-3,135
-9% -$111K 0.01% 787
2014
Q4
$1.35M Buy
35,544
+3,278
+10% +$120K 0.02% 716
2014
Q3
$1.15M Sell
32,266
-1,983
-6% -$73.7K 0.02% 1030
2014
Q2
$1.34M Sell
34,249
-2,135
-6% -$79.8K 0.02% 1027
2014
Q1
$1.32M Buy
36,384
+2,628
+8% +$95.8K 0.02% 1062
2013
Q4
$1.17M Buy
33,756
+19,261
+133% +$620K 0.02% 940
2013
Q3
$405K Sell
14,495
-13,234
-48% -$353K 0.01% 1653
2013
Q2
$747K Buy
+27,729
New +$766K 0.01% 1029

Other funds holding XYL

ProShare Advisors's XYL Position: Q2 2026 in Review

ProShare Advisors reduced its Xylem (XYL) stake by 2.9% in Q2 2026, selling an estimated $157K and leaving 45,661 shares worth $5.4M. The position accounts for 0.01% of the portfolio, ranked #552.

ProShare Advisors first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.1M in Q3 2024. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • ProShare Advisors held 45,661 shares of Xylem worth $5.4M as of Q2 2026.
  • ProShare Advisors sold 1,364 Xylem shares in Q2 2026, an estimated $157K.
  • Xylem made up 0.01% of ProShare Advisors's portfolio in Q2 2026, its #552 holding.
  • ProShare Advisors first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • ProShare Advisors's Xylem position peaked at $11.1M in Q3 2024.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.